Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

Behçet disease (BD) is a multisystem disease associated with a poor prognosis in cases of gastrointestinal, neurological, or vascular involvement. We conducted a multicenter, prospective, open-label, single-arm phase 3 study to determine the efficacy, safety, and pharmacokinetics of infliximab (IFX)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibi, Toshifumi, Hirohata, Shunsei, Kikuchi, Hirotoshi, Tateishi, Ukihide, Sato, Noriko, Ozaki, Kunihiko, Kondo, Kazuoki, Ishigatsubo, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998455/
https://www.ncbi.nlm.nih.gov/pubmed/27310969
http://dx.doi.org/10.1097/MD.0000000000003863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998455/
https://www.ncbi.nlm.nih.gov/pubmed/27310969
http://dx.doi.org/10.1097/MD.0000000000003863

Ejemplares similares